Form 4: Darling Ingredients EVP Acquires RSUs, Disposes Shares

Sentiment:

Insider Transaction Report


Darling Ingredients EVP Jeroen Colpaert reported the acquisition of 9,272 Restricted Stock Units and the disposal of 3,012 shares of common stock.

Summary

  • Jeroen Colpaert, EVP Rousselot at Darling Ingredients Inc. (DAR), reported changes in his beneficial ownership of common stock.
  • On January 3, 2026, Colpaert disposed of 3,012 shares of common stock at a price of $37.64 per share.
  • Following this disposition, Colpaert beneficially owned 15,820 shares of common stock directly.
  • On January 5, 2026, Colpaert acquired 9,272 shares of common stock through an award of Restricted Stock Units (RSUs) at a price of $37.56 per share.
  • These RSUs were issued under the Darling Ingredients Inc. 2017 Omnibus Incentive Plan and will vest in three equal installments of 33-1/3% on each of the first three anniversaries of the grant date.
  • After the RSU acquisition, Colpaert's direct beneficial ownership increased to 25,092 shares of common stock.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive due to a significant RSU award to a key executive, indicating continued alignment with company performance. The disposition of shares is likely for tax purposes and does not necessarily reflect a negative outlook.

Positives

  • Jeroen Colpaert, EVP Rousselot, received an award of 9,272 Restricted Stock Units (RSUs), aligning his interests with long-term shareholder value.
  • The RSU award demonstrates continued incentive and commitment from a key executive.

Negatives

  • Jeroen Colpaert disposed of 3,012 shares of common stock, which may represent tax withholding related to the vesting of previous equity awards.

Future Outlook

The 9,272 Restricted Stock Units granted to Jeroen Colpaert will vest in three equal installments of 33-1/3% on each of the first three anniversaries of the grant date (January 5, 2026).

Management Comments

  • The filing was signed by Teun Tchornobay, as Attorney-in-Fact for Jeroen Colpaert, indicating the use of a Power of Attorney for SEC filings.

Industry Context

This Form 4 filing details routine insider transactions related to executive compensation, which is a standard practice across publicly traded companies. It does not provide broader industry trends or competitive analysis.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Power of Attorney EstablishmentJeroen Colpaert executed a Power of Attorney on November 5, 2025, appointing Nick Kemphaus, Teun Tchornobay, and Bipasha Mukherjee as attorneys-in-fact. This grants them authority to prepare, execute, and submit SEC filings (Forms 3, 4, 5, and 144) on his behalf, manage his EDGAR Next account, and perform related actions.11/05/2025Enhances efficiency and compliance for insider reporting by allowing designated individuals to handle SEC filing requirements for the executive. It clarifies responsibilities and ensures timely submissions.

Stakeholder Impact

  • Shareholders: The RSU award aligns executive interests with long-term shareholder value, potentially fostering sustained performance.
  • Employees: The RSU award is part of the company's incentive plan, which can influence overall compensation strategy and employee motivation.

Next Steps

  • The Restricted Stock Units will vest in three annual installments, starting on the first anniversary of the January 5, 2026 grant date.

Key Dates

DateDescription
11/05/2025Date of execution of the Power of Attorney by Jeroen Colpaert.
01/03/2026Transaction date for the disposition of 3,012 shares of common stock.
01/05/2026Transaction date for the acquisition of 9,272 Restricted Stock Units (RSUs).
01/06/2026Signature date of the Form 4 filing by Teun Tchornobay, as Attorney-in-Fact for Jeroen Colpaert.
03/18/2028Expiration date of Notary Public Limmany Namuonglo's ID.

Keywords

Darling Ingredients, DAR, Insider Trading, Form 4, Restricted Stock Units, RSU, Executive Compensation, Stock Award, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.